v3.26.1
SHARE-BASED COMPENSATION PLANS (Tables)
 12 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense
Total share-based compensation is shown in the table below:
202620252024
Equity plan expense (a)
$46.1 $49.9 $88.5 
Liability plan expense0.2 0.1 0.3 
Total share-based compensation expense(b)
$46.3 $50.0 $88.8 
Income tax benefits recognized in earnings related to share-based compensation$2.7 $2.1 $3.0 
(Deficiencies) Excess tax benefits related to share-based compensation$2.0 $(0.4)$1.1 
(a) Equity plan shared-based compensation expense of $46.1, $49.9, and $88.5 was recorded to additional paid in capital and presented in the Consolidated Statement of Equity for the fiscal years ended June 30, 2026, 2025, and 2024, respectively.
(b)Expenses relating to share-based awards granted to non-Coty employees (Wella) are recorded within Other expense (income), net, within the Consolidated Statement of Operations.
Schedule of qualified stock options The fair value of the Company’s outstanding qualified stock options was estimated with the following assumptions:
2026
Expected term (in years)3.6
Expected volatility60.00 %
Risk-free interest rate4.10 %
Expected dividend yield— %
Schedule of outstanding nonqualified stock option activity
The Company’s outstanding qualified stock options as of June 30, 2026 and activity during the fiscal year then ended are presented below:
Shares (in millions)Weighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at July 1, 20250.0— 
Granted6.0$2.22 
Outstanding at June 30, 20266.0$2.22 
Vested and expected to vest at June 30, 20265.8 $2.22 2.5$— 
Exercisable at June 30, 2026— — $— 
The Company’s outstanding non-qualified stock options as of June 30, 2026 and activity during the fiscal year then ended are presented below:
Shares
(in millions)		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Term (in years)		Aggregate Intrinsic Value
Outstanding at July 1, 20253.4 $13.89 
Forfeited(0.6)$17.68 
Outstanding at June 30, 20262.8 $13.08 
Vested and expected to vest at June 30, 20262.8 $13.08 2.18$— 
Exercisable at June 30, 20262.8 $13.08 2.18$— 
Schedule of outstanding RSU and restricted stock activity
The Company’s outstanding RSUs as of June 30, 2026 and activity during the fiscal year then ended are presented below:
Shares
(in millions)		Weighted Average
Grant Date
Fair Value
Nonvested at July 1, 202519.1 $9.72 
Granted12.0 $3.14 
Vested(9.4)$9.17 
Forfeited(6.8)10.37 
Nonvested at June 30, 202614.9 $4.44 
The Company’s outstanding PRSUs as of June 30, 2026 and activity during the fiscal year then ended are presented below:
Shares
(in millions)		Weighted Average Grant Date Fair Value
Nonvested at July 1, 20259.0 $9.20 
Vested(1.1)$6.62 
Forfeited(4.8)$10.03 
Nonvested at June 30, 20263.1 $8.79